Review Article
Brachytherapy for Prostate Cancer: A Systematic Review
Table 2
LDR brachytherapy: clinical results for patients with intermediate-risk prostate cancer.
| Author | Number of patients | PSA relapse Definition | Median followup | Years after diagnosis | % of biochimical free reccurence |
| Ellis et al. [21] | 239 | ASTRO | 47 MONTHS | 7 | 87 | Zelefsky et al. [22] | 47 | ASTRO | 63 MONTHS | 5 | 89 | Zelefsky et al. [23] | 960 | ASTRO | 63 MONTHS | 8 | 70 | Khaksar et al. [25] | 111 | ASTRO | 45 MONTHS | 5 | 89 | Guedea et al. [26] | 119 | ASTRO | 30 MONTHS | 3 | 88 | Stock et al. [14] | 318 | ASTRO | 4.2 YEARS | 10 | 89.5 | Potters et al. [28] | 554 | ASTRO | 96 MONTHS | 12 | 78 | Sharkey et al. [29] | 1707 | ASTRO | — | 12 | 89 | Joseph et al. [30] | 667 | ASTRO | 31 MONTHS | 8 | 73.9 | Critz and Levinson [31] | 1469 | 0.2 ng/mL | 6 YEARS | 10 | 80 | Battermann et al. [33] | 114 | ASTRO | 48 MONTHS | 5 | 75 | Sylvester et al. [35] | 92 | 2 PSA rises | 63 MONTHS | 10 | 77 | Koutrouvelis et al. [41] | 68 | ASTRO | 4 YEARS | 5 | 95 | Kwok et al. [36] | 33 | ASTRO | 7 YEARS | 5 | 63 | Merrick et al. [40] | 273 | ASTRO | 4.7 YEARS | 8 | 94.8 |
|
|